To Study the Relationship between Obesity and Anti-Mullerian Hormone: As a Serum Marker of Ovarian Reserve In premenopausal Women
نویسندگان
چکیده
This study was performed with an objective to study the relationship between obesity and AMH as a serum marker of ovarian reserve in premenopausal women. We performed a cross-sectional comparative study of two agematched groups of late premenopausal participants: 50 participants (“non-obese”) had a BMI < 30 kg/m 2 , and the other 50 participants (“obese”) had a BMI of 30 to 35 kg/m 2 .The obese women had a mean age of 42.7 years and the non-obese women had a mean age of 43.1 years. Blood samples were collected from all participants and anthropometric measurements were calculated. The blood samples were assayed for antimüllerian hormone (AMH). The AMH level in group A (Obese) was 1.2 + 0.2 ng/ml which was significantly lower as compared to group B (Non-Obese)1.7 + 0.5 ng/ml (p< 0.01).BMI is also significantly correlated with serum AMH level ( r = 0.531, p< 0.01). In conclusion, there was significant difference in serum levels of AMH between obese and non-obese women indicating that obesity is likely to affect ovarian reserve in the premenopausal age group.
منابع مشابه
Evaluation of Ovarian Reserve by Measurement of the Serum Levels of Anti-Mullerian Hormone and Follicle-Stimulating Hormone in Intracytoplasmic Sperm Injection Cycles
Background It is important to evaluate ovarian reserves prior to intracytoplasmic sperm injection (ICSI) treatment. The aim of this study is to determine the accuracy of anti-mullerian hormone (AMH) as a marker for ovarian reserve and to compare it with day-3 serum follicle-stimulating hormone (FSH) levels. MaterialsAndMethods In this analytic, corss-sectional study, sequential sampling was don...
متن کاملP-75: Role of Anti-Mullerian Hormone in Prediction of Assisted Reproductive Technology Outcomes
Background: Anti-Mullerian hormone (AMH) has been suggested as a marker of ovarian reserve and predictor of ovarian response to controlled ovarian hyper stimulation. The aim of this study is to determine the role of AMH in prediction of success ART cycles in patients with normal FSH serum levels. Materials and Methods: This prospective cohort study included 80 infertile women under 4o years, wh...
متن کاملFollicle Stimulating Hormone and Anti-Mullerian Hormone Among Fertile and Infertile Women in Ile-ife, Nigeria: is There a Difference?
Background Reduced ovarian reserve has been known to predict poor ovarian response and poor success rates in infertile women undergoing assisted reproductive technology. Ovarian reserve also decreases with age but the rate of decline defers from a woman to another. The aim of this study was to detect any difference in ovarian reserve as measured by basal serum FSH and AMH between matched cohort...
متن کاملPnm-5: Anti-Mullerian Hormone in The Assessment and follow up of Cancer in Young Females
Background The impact of cancer therapy on the reproductive potential of patients is increasingly recognized because survival rates of patients have clearly improved in recent years. The study stressed the use of AMH may allow better prediction of chemotherapy-related risk to further fertility. MaterialsAndMethods A narrative review was performed within articles published at PubMed, Elsevier, S...
متن کاملRelationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Anti-Mullerian hormone (AMH) is a valid indicator of ovarian function and is used for PCOS diagnosis. Some studies have shown that adipokines affect the synthesis of AMH, and therefore they are somehow related in function. The aim of the present study was to determine the relationshi...
متن کامل